[EXEMPT - Expanded Access] An open-label, multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in adult patients with newly diagnosed Fms-like tyrosine kinase receptor (FLT3) mutated Acute Myeloid Leukemia (AML) who are eligible for standard induction and consolidation chemotherapy

UCI-16-04
Cancer - Myeloid and Monocytic Leukemia
Deepa Jeyakumar
Open
Treatment
Cytarabine, Daunorubicin, Idarubicin, Midostaurin
NA
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.